![](https://endpts.com/wp-content/uploads/2020/12/Chris-Chen-Getty-scaled.jpg)
Chris Chen, WuXi Biologics CEO (Photographer: Anthony Kwan/Bloomberg via Getty Images)
WuXi Biologics’ ADC spinout reports revenue jump despite Biosecure risk
ADCs are so hot that WuXi Biologics’ specialist company has so far appeared immune to the Biosecure threat as it unveiled a rise in revenues …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.